The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a “should” rather than a “may” recommendation for ages 12-15 and for ages 16-17 as well.
from WebMD Health https://ift.tt/3t1XaQ3
The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a “should” rather than a “may” recommendation for ages 12-15 and for ages 16-17 as well.
0 comments:
Post a Comment